IL-1/IL-1R Signaling in Head and Neck Cancer

• Published in: Frontiers in oral health Vol. 2; p. 722676
• Main Authors: Niklander, Sven E., Murdoch, Craig, Hunter, Keith D.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 26.08.2021
• Subjects: Anakinra (PubChem CID: 90470007); head and neck cancer; IL-1; oral cancer; Oral Health; squamous cell carcinoma; tumor microenvironment; Anakinra (PubChem CID: 90470007); tumor microenvironment; head and neck cancer; IL-1; oral cancer; squamous cell carcinoma
• ISSN: 2673-4842; 2673-4842
• DOI: 10.3389/froh.2021.722676

Decades ago, the study of cancer biology was mainly focused on the tumor itself, paying little attention to the tumor microenvironment (TME). Currently, it is well recognized that the TME plays a vital role in cancer development and progression, with emerging treatment strategies focusing on different components of the TME, including tumoral cells, blood vessels, fibroblasts, senescent cells, inflammatory cells, inflammatory factors, among others. There is a well-accepted relationship between chronic inflammation and cancer development. Interleukin-1 (IL-1), a potent pro-inflammatory cytokine commonly found at tumor sites, is considered one of the most important inflammatory factors in cancer, and has been related with carcinogenesis, tumor growth and metastasis. Increasing evidence has linked development of head and neck squamous cell carcinoma (HNSCC) with chronic inflammation, and particularly, with IL-1 signaling. This review focuses on the most important members of the IL-1 family, with emphasis on how their aberrant expression can promote HNSCC development and metastasis, highlighting possible clinical applications.